Adial Pharmaceuticals, Inc. (ADIL)
1.69
-0.04
(-2.31%)
USD |
NASDAQ |
Apr 02, 16:00
1.66
-0.03
(-1.78%)
After-Hours: 20:00
Adial Pharmaceuticals EPS Diluted (Quarterly) : -1.797 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Acurx Pharmaceuticals, Inc. | -0.6722 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1341 |
| BioMarin Pharmaceutical, Inc. | -0.2423 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.996M |
| Total Expenses (Quarterly) | 1.996M |
| Enterprise Value | -4.003M |
| Earnings Yield | -525.0% |
| Normalized Earnings Yield | -524.97 |